Early research (Phase 1)Ended earlyNCT00887926What this trial is testingStudy of IMC-EB10 in Participant With LeukemiaWho this might be right forMyeloid Leukemia Eli Lilly and Company 25
Early research (Phase 1)Ended earlyNCT01743807What this trial is testingPhase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous LeukemiaWho this might be right forRelapsed Acute Lymphoblastic LeukemiaRelapsed Acute Myelogenous Leukemia Therapeutic Advances in Childhood Leukemia Consortium 4
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Early research (Phase 1)UnknownNCT00004036What this trial is testingCombination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more The Cleveland Clinic 30
Early research (Phase 1)Study completedNCT00004932What this trial is testingSTI571 in Treating Patients With Recurrent LeukemiaWho this might be right forLeukemia Children's Oncology Group 31
Testing effectiveness (Phase 2)UnknownNCT05241106What this trial is testingHYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forRelapsed or Refractory Acute Myeloid Leukemia (AML) Tarapeutics Science Inc. 15
Early research (Phase 1)UnknownNCT06049667What this trial is testingClinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological MalignanciesWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia (AML) Nanjing Chia-tai Tianqing Pharmaceutical 72
Early research (Phase 1)Study completedNCT00053963What this trial is testingFR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT03576547What this trial is testingVenetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous LeukemiaWho this might be right forBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome PositiveRecurrent Acute Lymphoblastic Leukemia+4 more M.D. Anderson Cancer Center 9
Early research (Phase 1)Looking for participantsNCT06649227What this trial is testingStudy Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19Who this might be right forRelapsed Adult AML University Hospital, Lille 5
Early research (Phase 1)Study completedNCT00003294What this trial is testingChemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Roswell Park Cancer Institute 24
Early research (Phase 1)Study completedNCT00268229What this trial is testingImatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid LeukemiaWho this might be right forLeukemia The Cleveland Clinic 21
Testing effectiveness (Phase 2)Study completedNCT00002554What this trial is testingMonoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First RelapseWho this might be right forLeukemia Fred Hutchinson Cancer Center 30
Early research (Phase 1)Ended earlyNCT03465540What this trial is testingSafety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological MalignanciesWho this might be right forMultiple MyelomaAcute Myeloid LeukemiaNon-Hodgkins Lymphoma+4 more Amgen 24
Early research (Phase 1)Not Yet RecruitingNCT07616089What this trial is testingPhase I Study of FXS0683 in the Treatment of Blood TumorsWho this might be right forB-Cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 228
Early research (Phase 1)Looking for participantsNCT05986240What this trial is testingDanvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AMLWho this might be right forAML/MDSAcute Myeloid LeukemiaMyelodysplastic Syndromes Montefiore Medical Center 38
Testing effectiveness (Phase 2)Study completedNCT05024994What this trial is testingE7820 in People With Bone Marrow (Myeloid) CancersWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT01135329What this trial is testingReduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic CancersWho this might be right forLymphomaLeukemiaMyelodysplastic Syndrome Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Ended earlyNCT00450983What this trial is testingDonor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01664897What this trial is testingErlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+8 more M.D. Anderson Cancer Center 29